Evidence map›Paper›PMID 35571794›Full record

ArticleACS omega2022

Andreas H Laustsen, Bengt H Gless, Timothy P Jenkins, Maria Meyhoff-Madsen, Johanna Bjärtun, Andreas S Munk, Saioa Oscoz, Julián Fernández, José María Gutiérrez, Bruno Lomonte and 1 more

Open access · goldAbstract read
In one paragraph

Article in ACS omega, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Research square · 2024
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Andreas H LaustsenDepartment of Biotechnology and Biomedicine, Technical University of Denmark, Lyngby DK-2800, Denmark.ORCID https://orcid.org/0000-0001-6918-5574
Bengt H GlessDepartment of Drug Design and Pharmacology, University of Copenhagen, Copenhagen DK-2100, Denmark.ORCID https://orcid.org/0000-0003-0935-3278
Timothy P JenkinsDepartment of Biotechnology and Biomedicine, Technical University of Denmark, Lyngby DK-2800, Denmark.
Maria Meyhoff-MadsenDepartment of Drug Design and Pharmacology, University of Copenhagen, Copenhagen DK-2100, Denmark.
Johanna BjärtunDepartment of Drug Design and Pharmacology, University of Copenhagen, Copenhagen DK-2100, Denmark.
Andreas S MunkDepartment of Biotechnology and Biomedicine, Technical University of Denmark, Lyngby DK-2800, Denmark.
Saioa OscozDepartment of Biotechnology and Biomedicine, Technical University of Denmark, Lyngby DK-2800, Denmark.
Julián FernándezInstituto Clodomiro Picado, Faculty of Microbiology, University of Costa Rica, San José 11501-2060, Costa Rica.
José María GutiérrezInstituto Clodomiro Picado, Faculty of Microbiology, University of Costa Rica, San José 11501-2060, Costa Rica.
Bruno LomonteInstituto Clodomiro Picado, Faculty of Microbiology, University of Costa Rica, San José 11501-2060, Costa Rica.ORCID https://orcid.org/0000-0003-2419-6469
Brian LohseDepartment of Drug Design and Pharmacology, University of Copenhagen, Copenhagen DK-2100, Denmark.
Technical University of Denmark · DKUniversity of Copenhagen · DKUniversidad de Costa Rica · CR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Many snake venom toxins cause local tissue damage in prey and victims, which constitutes an important pathology that is challenging to treat with existing antivenoms. One of the notorious toxins that causes such effects is myotoxin II present in the venom of the Central and Northern South American viper,

Identifiers

PMID35571794
PMCPMC9096979
OpenAlexW4280549131

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.